REGENERON PHARMACEUTICALS
REGN·75886F107·US·Common Stock·Healthcare - Biotechnology-13D/G
REGN (REGENERON PHARMACEUTICALS) is held by 314 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($5.7B), VANGUARD CAPITAL MANAGEMENT LLC ($4.1B), DODGE & COX ($3B). Net institutional sentiment: Mixed. In Q2 2026, 7 members of Congress and 164 funds bought REGN.
314
Holders
(30 Elite)
$51.1B
Total Value
51% (321)
Consensus
164 buying - 157 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 21, 2026 · Activists Apr 30, 2026 · Congress Jul 21, 2026
InsiderLJLAROSA JOSEPH JTax 9K shAug 19, 2026
InsiderLJLAROSA JOSEPH JExercise 12K shAug 19, 2026
InsiderFRFenimore Christopher R.Tax 5K shAug 18, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 326
1 / 17
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer